Exchange Traded Concepts, LLC Karuna Therapeutics, Inc. Transaction History

Exchange Traded Concepts, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 05, 2024	BUY	$161.01 - $317.85 $1,449 - $2,860	9 Added 1.99%	461 $145,000
Q3 2023 Oct 18, 2023	BUY	$164.66 - $218.08 $19,100 - $25,297	116 Added 34.52%	452 $76,000
Q2 2023 Jul 20, 2023	SELL	$176.32 - $240.22 $1,057 - $1,441	-6 Reduced 1.75%	336 $72,000
Q1 2023 Apr 12, 2023	BUY	$161.33 - $204.36 $55,174 - $69,891	342 New	342 $62,000
Q1 2022 Apr 26, 2022	SELL	$98.9 - $132.37 $23,834 - $31,901	-241 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$110.64 - $159.4 $8,298 - $11,955	75 Added 45.18%	241 $32,000
Q3 2021 Oct 18, 2021	BUY	$101.2 - $125.87 $4,655 - $5,790	46 Added 38.33%	166 $20,000
Q2 2021 Jul 30, 2021	BUY	$107.45 - $135.95 $12,894 - $16,313	120 New	120 $14,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.